Skip to content
VuFind
English
Deutsch
Español
Français
Italiano
日本語
Nederlands
Português
Português (Brasil)
中文(简体)
中文（繁體）
Türkçe
עברית
Gaeilge
Cymraeg
Ελληνικά
Català
Euskara
Русский
Čeština
Suomi
Svenska
polski
Dansk
slovenščina
اللغة العربية
বাংলা
Galego
Tiếng Việt
Hrvatski
हिंदी
Հայերէն
Українська
Sámegiella
Монгол
Jezik
Vsa polja
Naslov
Avtor
Tema
Signatura
ISBN/ISSN
Oznaka
Išči
Napredno
Osteoprotegerin inhibits the d...
Citiraj
Pošljite SMS
Pošljite email
Natisni
Izvozi zadetek
Izvozi v RefWorks
Izvozi v EndNoteWeb
Izvozi v EndNote
Permanent link
Osteoprotegerin inhibits the development of osteolytic bone disease in multiple myeloma
Show other versions (1)
Bibliografske podrobnosti
Main Authors:
Croucher, P
,
Shipman, C
,
Perry, M
,
Lippitt, J
,
Asosingh, K
,
van Beek, E
,
Van Camp, B
,
Russell, R
,
Dunstan, C
,
Vanderkerken, K
Format:
Journal article
Izdano:
2001
Zaloga
Opis
Other Versions (1)
Podobne knjige/članki
Knjižničarski pogled
Podobne knjige/članki
Osteoprotegerin inhibits the development of osteolytic bone disease in multiple myeloma.
od: Croucher, P, et al.
Izdano: (2001)
Osteoprotegerin (OPG) inhibits the development of osteolytic bone disease in the 5T2MM model of multiple myeloma.
od: Croucher, P, et al.
Izdano: (2000)
Bisphosphonates and osteoprotegerin as inhibitors of myeloma bone disease.
od: Croucher, P, et al.
Izdano: (2003)
Zoledronic acid inhibits the development of osteolytic bone disease and increases disease free survival in a murine model of multiple myeloma.
od: Croucher, P, et al.
Izdano: (2001)
Osteoprotegerin and the development of myeloma bone disease
od: Croucher, P, et al.
Izdano: (2004)